Clarithromycin or Rifabutin Alone or in Combination for Primary Prophylaxis ofMycobacterium aviumComplex Disease in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Citations Over TimeTop 10% of 2000 papers

Abstract

The efficacy and safety of clarithromycin and rifabutin alone and in combination for prevention of Mycobacterium avium complex (MAC) disease were compared in 1178 patients with AIDS who had < or =100 CD4 T cells/microL in a randomized, double-blind, placebo-controlled trial. MAC disease occurred in 9%, 15%, and 7% of those randomized to clarithromycin or rifabutin alone or in combination, respectively; time-adjusted event rates per 100 patient-years (95% confidence interval [CI]) were 6.3 (4.2-8.3), 10.5 (7.8-13.2), and 4. 7 (2.9-6.5). Risk of MAC disease was reduced by 44% with clarithromycin (risk ratio [RR], 0.56; 95% CI, 0.37-0.84; P=.005) and by 57% with combination therapy (RR, 0.43; 95% CI, 0.27-0.69; P=. 0003), versus rifabutin. Combination therapy was not more effective than clarithromycin (RR, 0.79; 95% CI, 0.48-1.31; P=.36). Of those in whom clarithromycin or combination therapy failed, 29% and 27% of MAC isolates, respectively, were resistant to clarithromycin. There were no survival differences. Clarithromycin and combination therapy were more effective than rifabutin for prevention of MAC disease, but combination therapy was associated with more adverse effects (31%; P<.001).

Related Papers

• → Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare Infection(1995)178 cited
• → Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS(1993)396 cited
• → Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex(1994)3 cited
• → OUTCOMES AND COSTS OF SHORT- AND LONGTERM RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM AVIUM (MAC) DISEASE IN AIDS PATIENTS IN THE UNITED KINGDOM(1994)1 cited
• → Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile?(1996)